ARCHIVES

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

This article is from The Cancer Letter archive.

Vol. 15 No. 37 | September 29, 1989

Download PDF Visit The Full Archive

Related Articles

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

1978, ’79 budget Projections By Research Programs

November 25, 1977

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996